Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127298031 | 12729803 | 1 | I | 20160830 | 20160909 | 20160909 | EXP | CO-009507513-1609COL004786 | MERCK | 60.00 | YR | M | Y | 0.00000 | 20160909 | CN | US | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127298031 | 12729803 | 1 | SS | EFAVIRENZ | EFAVIRENZ | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 127298031 | 12729803 | 2 | PS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | UNK MG, UNK | 22145 | TABLET | |||||||||
| 127298031 | 12729803 | 3 | C | TENOFOVIR | TENOFOVIR | 1 | 0 | ||||||||||||
| 127298031 | 12729803 | 4 | C | EMTRICITABINE | EMTRICITABINE | 1 | 0 | ||||||||||||
| 127298031 | 12729803 | 5 | C | sulfamethoxazole (+) trimethoprim | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127298031 | 12729803 | 1 | HIV infection |
| 127298031 | 12729803 | 2 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127298031 | 12729803 | DE |
| 127298031 | 12729803 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127298031 | 12729803 | Hepatic cirrhosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |